{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T22:24:16Z","timestamp":1755037456167},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5S","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,5]]},"abstract":"<jats:p>Lyme disease is a multisystem disease caused by <jats:italic toggle=\"yes\">Borrelia burgdorferi<\/jats:italic> infection and accounts for well-defined manifestations, appearing either at an early or late stage. Appropriate antibiotic therapy generally leads to a favorable outcome. Still, unspecific persisting symptoms such as fatigue, myalgia, arthralgia or cognitive dysfunction are reported by several patients months to years after adequate treatment. Their underlying pathophysiologic mechanism is unclear. However, there is no evidence for microbiological persistence in these cases and attempts to resolve the symptoms by repeated or prolonged antibiotic treatment have not been convincingly successful, but they may rather be harmful. To narrow down the controversially handled entity of posttreatment Lyme disease syndrome (PTLDS) and to avoid overdiagnosis and overtreatment, case definitions have been proposed, acknowledging PTLDS as a complex of nonspecific, subjective symptoms, which are neither caused by ongoing infection nor by any other identifiable disease. PTLDS is mainly a diagnosis of exclusion and requires careful evaluation of differential diagnosis followed by counseling about optimal management in light of missing specific therapeutic options.<\/jats:p>","DOI":"10.1097\/inf.0000000000002772","type":"journal-article","created":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T18:47:12Z","timestamp":1622141232000},"page":"S31-S34","source":"Crossref","is-referenced-by-count":3,"title":["Posttreatment Lyme Disease Syndrome\u2014What It Might Be and What It Is Not"],"prefix":"10.1097","volume":"40","author":[{"given":"Hanna","family":"Schmid","sequence":"first","affiliation":[{"name":"From the University of Basel Children\u2019s Hospital, Paediatric Infectious Diseases and Vaccinology, Basel, Switzerland."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich","family":"Heininger","sequence":"additional","affiliation":[{"name":"From the University of Basel Children\u2019s Hospital, Paediatric Infectious Diseases and Vaccinology, Basel, Switzerland."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,5,26]]},"reference":[{"key":"R1-20230912","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/art.1780200102","article-title":"Lyme arthritis: an epidemic of oligoarticular arthritis in children and adults in three Connecticut communities.","volume":"20","author":"Steere","year":"1977","journal-title":"Arthritis Rheum"},{"key":"R2-20230912","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1126\/science.7043737","article-title":"Lyme disease-a tick-borne spirochetosis?","volume":"216","author":"Burgdorfer","year":"1982","journal-title":"Science"},{"key":"R3-20230912","first-page":"874","article-title":"[Tick bite and Lyme borreliosis. An epidemiologic study in the Erlangen area].","volume":"141","author":"Heininger","year":"1993","journal-title":"Monatsschr Kinderheilkd"},{"key":"R4-20230912","doi-asserted-by":"crossref","DOI":"10.1128\/AEM.00609-17","article-title":"Europe-wide meta-analysis of Borrelia burgdorferi Sensu Lato prevalence in questing Ixodes ricinus ticks.","volume":"83","author":"Strnad","year":"2017","journal-title":"Appl Environ Microbiol"},{"key":"R5-20230912","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1007\/s00431-012-1779-4","article-title":"Rational diagnostic strategies for Lyme borreliosis in children and adolescents: recommendations by the Committee for Infectious Diseases and Vaccinations of the German Academy for Pediatrics and Adolescent Health.","volume":"171","author":"Huppertz","year":"2012","journal-title":"Eur J Pediatr"},{"key":"R6-20230912","doi-asserted-by":"crossref","first-page":"e0181807","DOI":"10.1371\/journal.pone.0181807","article-title":"Predicting the risk of Lyme borreliosis after a tick bite, using a structural equation model.","volume":"12","author":"Hofhuis","year":"2017","journal-title":"PLoS One"},{"key":"R7-20230912","first-page":"113","article-title":"Seropr\u00e4valenz der Lyme-Borreliose bei Kindern und Jugend-lichen in Deutschland.","volume":"14","year":"2012","journal-title":"Epidemiol Bull"},{"key":"R8-20230912","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss6622a1","article-title":"Surveillance for Lyme disease\u2014United States, 2008-2015.","volume":"66","author":"Schwartz","year":"2017","journal-title":"MMWR Surveill Summ"},{"key":"R9-20230912","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.cll.2015.08.003","article-title":"Ecology and epidemiology of Lyme borreliosis.","volume":"35","author":"Schotthoefer","year":"2015","journal-title":"Clin Lab Med"},{"key":"R10-20230912","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jinf.2011.03.006","article-title":"The epidemiology, prevention, investigation and treatment of Lyme borreliosis in United Kingdom patients: a position statement by the British Infection Association.","volume":"62","year":"2011","journal-title":"J Infect"},{"key":"R11-20230912","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1469-0691.2010.03175.x","article-title":"Lyme borreliosis: clinical case definitions for diagnosis and management in Europe.","volume":"17","author":"Stanek","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"R12-20230912","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1001\/jama.2016.2884","article-title":"Diagnosis, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and Babesiosis: a review.","volume":"315","author":"Sanchez","year":"2016","journal-title":"JAMA"},{"key":"R13-20230912","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1086\/508667","article-title":"The clinical assessment, treatment, and prevention of Lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America.","volume":"43","author":"Wormser","year":"2006","journal-title":"Clin Infect Dis"},{"key":"R14-20230912","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.arcped.2019.02.010","article-title":"Lyme neuroborreliosis in children: report of nine cases and a review of the literature.","volume":"26","author":"Guet-Revillet","year":"2019","journal-title":"Arch Pediatr"},{"key":"R15-20230912","doi-asserted-by":"crossref","first-page":"e153","DOI":"10.1016\/j.ijid.2012.09.014","article-title":"Borrelia burgdorferi infection and Lyme disease in children.","volume":"17","author":"Esposito","year":"2013","journal-title":"Int J Infect Dis"},{"key":"R16-20230912","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s100960050381","article-title":"Incidence of Lyme borreliosis in the W\u00fcrzburg region of Germany.","volume":"18","author":"Huppertz","year":"1999","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R17-20230912","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1056\/NEJM199610243351703","article-title":"Lyme disease in children in southeastern Connecticut. Pediatric Lyme Disease Study Group.","volume":"335","author":"Gerber","year":"1996","journal-title":"N Engl J Med"},{"key":"R19-20230912","doi-asserted-by":"crossref","first-page":"16090","DOI":"10.1038\/nrdp.2016.90","article-title":"Lyme Borreliosis.","volume":"2","author":"Steere","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"R20-20230912","doi-asserted-by":"crossref","first-page":"703","DOI":"10.15585\/mmwr.mm6832a4","article-title":"Updated CDC recommendation for serologic diagnosis of Lyme disease.","volume":"68","author":"Mead","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R21-20230912","doi-asserted-by":"crossref","first-page":"e00547","DOI":"10.1128\/JCM.00547-19","article-title":"Evaluation of the modified two-tiered testing (MTTT) method for the diagnosis of Lyme disease in children.","volume":"57","author":"Lipsett","year":"2019","journal-title":"J Clin Microbiol"},{"key":"R22-20230912","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1001\/jama.2018.10974","article-title":"Lyme disease in 2018: what is new (and what is not).","volume":"320","author":"Shapiro","year":"2018","journal-title":"JAMA"},{"key":"R23-20230912","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.cmi.2017.08.025","article-title":"To test or not to test? Laboratory support for the diagnosis of Lyme borreliosis: a position paper of ESGBOR, the ESCMID study group for Lyme borreliosis..","volume":"24","author":"Dessau","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"R24-20230912","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1055\/s-0031-1287652","article-title":"Nervous system Lyme disease: is there a controversy?","volume":"31","author":"Halperin","year":"2011","journal-title":"Semin Neurol"},{"key":"R25-20230912","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s10096-007-0340-2","article-title":"Duration of antibiotic treatment in disseminated Lyme borreliosis: a double-blind, randomized, placebo-controlled, multicenter clinical study.","volume":"26","author":"Oksi","year":"2007","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"R26-20230912","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.idc.2015.02.011","article-title":"Lyme disease in children.","volume":"29","author":"Sood","year":"2015","journal-title":"Infect Dis Clin North Am"},{"key":"R27-20230912","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1056\/NEJM200107123450202","article-title":"Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease.","volume":"345","author":"Klempner","year":"2001","journal-title":"N Engl J Med"},{"key":"R28-20230912","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa1505425","article-title":"Randomized Trial of longer-term therapy for symptoms attributed to Lyme disease.","volume":"374","author":"Berende","year":"2016","journal-title":"N Engl J Med"},{"key":"R29-20230912","first-page":"w14353","article-title":"Update of the Swiss guidelines on post-treatment Lyme disease syndrome.","volume":"146","author":"Nemeth","year":"2016","journal-title":"Swiss Med Wkly"},{"key":"R30-20230912","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1212\/01.WNL.0000071227.23769.9E","article-title":"Study and treatment of post Lyme disease (STOP-LD): a randomized double masked clinical trial.","volume":"60","author":"Krupp","year":"2003","journal-title":"Neurology"},{"key":"R31-20230912","first-page":"935","article-title":"[Lyme disease Part 3: prevention, pregnancy, immunodeficient state, post-Lyme disease syndrome].","volume":"2","author":"Evison","year":"2006","journal-title":"Rev Med Suisse"},{"key":"R32-20230912","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.amjmed.2009.05.011","article-title":"Subjective symptoms after treatment of early Lyme disease.","volume":"123","author":"Cerar","year":"2010","journal-title":"Am J Med"},{"key":"R33-20230912","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1093\/cid\/cis402","article-title":"Treatment of erythema migrans with doxycycline for 10 days versus 15 days.","volume":"55","author":"Stupica","year":"2012","journal-title":"Clin Infect Dis"},{"key":"R34-20230912","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1097\/INF.0b013e31817fd423","article-title":"Lyme neuroborreliosis in children: a prospective study of clinical features, prognosis, and outcome.","volume":"27","author":"Skogman","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"R35-20230912","doi-asserted-by":"crossref","first-page":"e93","DOI":"10.1542\/peds.112.2.e93","article-title":"Long-term neuropsychologic and health outcomes of children with facial nerve palsy attributable to Lyme disease.","volume":"112","author":"V\u00e1zquez","year":"2003","journal-title":"Pediatrics"},{"key":"R36-20230912","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1002\/art.24314","article-title":"Role of psychiatric comorbidity in chronic Lyme disease.","volume":"59","author":"Hassett","year":"2008","journal-title":"Arthritis Rheum"},{"key":"R37-20230912","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.amjmed.2009.02.022","article-title":"Psychiatric comorbidity and other psychological factors in patients with \u201cchronic Lyme disease\u201d.","volume":"122","author":"Hassett","year":"2009","journal-title":"Am J Med"},{"issue":"suppl 4","key":"R38-20230912","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1289\/ehp.02110s4607","article-title":"Contributions of societal and geographical environments to \u201cchronic Lyme disease\u201d: the psychopathogenesis and aporology of a new \u201cmedically unexplained symptoms\u201d syndrome.","volume":"110","author":"Sigal","year":"2002","journal-title":"Environ Health Perspect"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000002772","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T22:23:24Z","timestamp":1694557404000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/INF.0000000000002772"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":37,"journal-issue":{"issue":"5S","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0000000000002772","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]}}}